Market research
SHPH Shuttle Pharmaceuticals Inc
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2M
- P/E ratio
- 35.3
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.22
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- US8256935003
- Market cap
- 2M
- P/E ratio
- 35.3
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.22
About
About Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the SHPH discussion.
No comments yet
Start a focused discussion about SHPH.